Search research articles
Contact Us
Filters
Showing results (201-210 of 334) with videos related to
Page
of 34
Sort By:
Veterinary Journal (London, England : 1997)
|
April 13, 2011
Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma
Saray Lorda Mayayo, Simone Prestigio, Lorella Maniscalco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2021
Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia
Eben I Lichtman, Hongwei Du, Peishun Shou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2013
T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo
Claudia Geldres, Barbara Savoldo, Valentina Hoyos, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 4, 2014
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation
Francesco Sabbatino, Celeste Fusciello, Domenico Somma, et al.
Cancer Immunology Research
|
May 15, 2015
STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients
Raghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Human Immunology
|
June 1, 2002
Molecular characterization of the HLA-Cw*0409N allele
Zhigang C Wang, Anajane G Smith, Edmond J Yunis, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2021
Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells
Claudia De Pasquale, Stefania Campana, Chiara Barberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes
Yasufumi Goto, Soldano Ferrone, Takaaki Arigami, et al.
Biomolecules
|
January 8, 2025
Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients
Barbara Hegyi, Kristóf György Csikó, Tímea Balatoni, et al.
Cancer Immunology, Immunotherapy : CII
|
June 11, 2011
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients
Fabio Morandi, Maria Valeria Corrias, Isabella Levreri, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 334) with videos related to
Sort By:
Page
of 34
Veterinary Journal (London, England : 1997)
|
April 13, 2011
Chondroitin sulfate proteoglycan-4: a biomarker and a potential immunotherapeutic target for canine malignant melanoma
Saray Lorda Mayayo, Simone Prestigio, Lorella Maniscalco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2021
Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia
Eben I Lichtman, Hongwei Du, Peishun Shou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2013
T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo
Claudia Geldres, Barbara Savoldo, Valentina Hoyos, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology
|
September 4, 2014
Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation
Francesco Sabbatino, Celeste Fusciello, Domenico Somma, et al.
Cancer Immunology Research
|
May 15, 2015
STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients
Raghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Human Immunology
|
June 1, 2002
Molecular characterization of the HLA-Cw*0409N allele
Zhigang C Wang, Anajane G Smith, Edmond J Yunis, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2021
Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells
Claudia De Pasquale, Stefania Campana, Chiara Barberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2008
Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes
Yasufumi Goto, Soldano Ferrone, Takaaki Arigami, et al.
Biomolecules
|
January 8, 2025
Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients
Barbara Hegyi, Kristóf György Csikó, Tímea Balatoni, et al.
Cancer Immunology, Immunotherapy : CII
|
June 11, 2011
Serum levels of cytoplasmic melanoma-associated antigen at diagnosis may predict clinical relapse in neuroblastoma patients
Fabio Morandi, Maria Valeria Corrias, Isabella Levreri, et al.
Page
of 34